Skip to main content
. 2019 Feb 16;110(3):1012–1020. doi: 10.1111/cas.13932

Figure 3.

Figure 3

Longitudinal changes in the sum of the longest target lesion diameters for each patient as assessed per RECIST version 1.1 per central review. PD‐L1, programmed death ligand 1; RECIST, Response Evaluation Criteria in Solid Tumors; TPS, tumor proportion score